May 14, 2002 Dear Pharmacy Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports o

First Page		Document Content
Medicine Cyclopropanes Abacavir Purines Organofluorides Lamivudine GlaxoSmithKline Zidovudine Fixed dose combination Chemistry Pharmacology		May 14, 2002 Dear Pharmacy Professional, We would like to call to your attention a situation involving counterfeit labeling of Combivir� (lamivudine plus zidovudine) Tablets. GlaxoSmithKline has received four reports o Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 16,24 KB Share Document on Facebook

	EUROPEAN PHARMACOPOEIA 8.4 INDEX To aid users the index includes a reference to the supplement in which the latest version of a text can be found. For example : Abacavir sulfate.......................................... DocID: 1qtmO - View Document
	“ตัวอย่างหน้าอนุมัติวทิ ยานิพนธ์ภาษาอังกฤษ กลุ่มวิทยาศาสตร์สุขภาพ” Thesis entitled “Associ DocID: 1pXIU - View Document
	ANTIRETROVIRAL PRIORITIES OF THE MEDICINES PATENT POOL DocID: 1fNy0 - View Document
	Antiviral Therapy 9:Simple linear model provides highly accurate genotypic predictions of HIV-1 drug resistance Kai Wang, Ekachai Jenwitheesuk, Ram Samudrala and John E Mittler* Department of Microbiology, Unive DocID: 1fvTD - View Document
	MULTI-‐TARGET PREDICTION Willem Waegeman NGDATA Europe Belgium DocID: 1aQSO - View Document